B Lymphocyte Depletion with the Monoclonal Antibody Rituximab in Graves’ Disease: A Controlled Pilot Study-Reference-Cited by-同舟云学术

B Lymphocyte Depletion with the Monoclonal Antibody Rituximab in Graves’ Disease: A Controlled Pilot Study

Published:2007-05-01 Issue:5 Volume:92 Page:1769-1772
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

El Fassi Daniel¹²,Nielsen Claus H.²,Bonnema Steen J.¹,Hasselbalch Hans C.³,Hegedüs Laszlo¹

Affiliation:

1. Department of Endocrinology and Metabolism (D.E.F., S.J.B., L.H.), Odense University Hospital, 5000 Odense, Denmark

2. Institute for Inflammation Research (D.E.F., C.H.N.), Rigshospitalet National University Hospital, 2100 Copenhagen, Denmark

3. Department of Hematology (H.C.H.), Odense University Hospital, 5000 Odense, Denmark

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/92/5/1769/9053497/jcem1769.pdf

Reference20 articles.

1. Graves’ disease.;Weetman;N Engl J Med,2000

2. Quality of life in patients with benign thyroid disorders. A review.;Watt;Eur J Endocrinol,2006

3. Antithyroid drugs.;Cooper;N Engl J Med,2005

4. Serum thyrotropin receptor antibodies concentrations in patients with Graves’ disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.;Carella;Thyroid,2006

5. B-cell targeting in rheumatoid arthritis and other autoimmune diseases.;Edwards;Nat Rev Immunol,2006

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graves disease: latest understanding of pathogenesis and treatment options;Nature Reviews Endocrinology;2024-07-22

2. Effects of Low-dose Methotrexate With Methimazole in Patients With Graves’ Disease: Results of a Randomized Clinical Trial;The Journal of Clinical Endocrinology & Metabolism;2024-07-12

3. Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy;Advanced Therapeutics;2024-07-05

4. Le terapie a bersaglio molecolare nel trattamento del morbo di Basedow;L'Endocrinologo;2024-03-06

5. Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations;Rheumatology Science and Practice;2023-10-27